Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · IEX Real-Time Price · USD
3.76
+0.03 (0.80%)
Aug 8, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Net Income
-125.6-67.25-35.26-8.93-4.6
Depreciation & Amortization
0.210.050.050.040.02
Share-Based Compensation
14.047.773.640.060.01
Other Operating Activities
11.217.296.890.372.22
Operating Cash Flow
-100.15-52.15-24.67-8.45-2.35
Capital Expenditures
-2.71-0.14-0.02-0.08-0.08
Change in Investments
133.32-281.55000
Investing Cash Flow
130.61-281.69-0.02-0.08-0.08
Share Issuance / Repurchase
0.73214.94000.1
Debt Issued / Paid
0000-0.05
Other Financing Activities
00127.7652.319.92
Financing Cash Flow
0.73214.94127.7652.319.97
Net Cash Flow
31.19-118.89103.0643.787.55
Free Cash Flow
-102.86-52.29-24.7-8.53-2.43
Free Cash Flow Per Share
-2.84-1.59-11.90-4.23-1.26
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).